N Theodore|J J Lynch - JoVE Visualize

Showing results (171-180 of 211) with videos related to

Pageof 22

Sort By:

Pharmaceutical Research|March 1, 1994

Pharmacokinetics and pharmacodynamics of L-703,014, a potent fibrinogen receptor antagonist, after intravenous and oral administration in the dogJ S Barrett, R J Gould, J D Ellis, et al.

Circulation|July 1, 1991

Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbitsS J Gardell, D R Ramjit, I I Stabilito, et al.

The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993

Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosisD R Ramjit, J J Lynch, G R Sitko, et al.

Journal of Medicinal Chemistry|August 5, 1994

Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-AspM S Egbertson, C T Chang, M E Duggan, et al.

Stem Cell Reports|April 19, 2017

Distinct Roles for Matrix Metalloproteinases 2 and 9 in Embryonic Hematopoietic Stem Cell Emergence, Migration, and Niche ColonizationLindsay N Theodore, Elliott J Hagedorn, Mauricio Cortes, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995

Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383J J Lynch, J J Cook, G R Sitko, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994

Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]J J Lynch, A A Wallace, R F Stupienski, et al.

Computer Methods and Programs in Biomedicine|November 12, 2022

Multi-perspective region-based CNNs for vertebrae labeling in intraoperative long-length imagesY Huang, C K Jones, X Zhang, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993

Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agentJ J Lynch, A A Wallace, L H Van der Gaag, et al.

Cancer|August 10, 2000

Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influencesJ S Mandelblatt, J Hadley, J F Kerner, et al.

Pageof 22

Showing results (171-180 of 211) with videos related to

Sort By:

Pageof 22

Pharmaceutical Research|March 1, 1994

Pharmacokinetics and pharmacodynamics of L-703,014, a potent fibrinogen receptor antagonist, after intravenous and oral administration in the dogJ S Barrett, R J Gould, J D Ellis, et al.

Circulation|July 1, 1991

Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbitsS J Gardell, D R Ramjit, I I Stabilito, et al.

The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993

Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosisD R Ramjit, J J Lynch, G R Sitko, et al.

Journal of Medicinal Chemistry|August 5, 1994

Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-AspM S Egbertson, C T Chang, M E Duggan, et al.

Stem Cell Reports|April 19, 2017

Distinct Roles for Matrix Metalloproteinases 2 and 9 in Embryonic Hematopoietic Stem Cell Emergence, Migration, and Niche ColonizationLindsay N Theodore, Elliott J Hagedorn, Mauricio Cortes, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 1, 1995

Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383J J Lynch, J J Cook, G R Sitko, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1994

Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]J J Lynch, A A Wallace, R F Stupienski, et al.

Computer Methods and Programs in Biomedicine|November 12, 2022

Multi-perspective region-based CNNs for vertebrae labeling in intraoperative long-length imagesY Huang, C K Jones, X Zhang, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993

Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agentJ J Lynch, A A Wallace, L H Van der Gaag, et al.

Cancer|August 10, 2000

Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influencesJ S Mandelblatt, J Hadley, J F Kerner, et al.

Pageof 22